1170 related articles for article (PubMed ID: 26843613)
21. MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity
Son DJ; Zheng J; Jung YY; Hwang CJ; Lee HP; Woo JR; Baek SY; Ham YW; Kang MW; Shong M; Kweon GR; Song MJ; Jung JK; Han SB; Kim BY; Yoon DY; Choi BY; Hong JT
Theranostics; 2017; 7(18):4632-4642. PubMed ID: 29158850
[No Abstract] [Full Text] [Related]
22. Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer.
Li Y; Sun H; Bai C; Hu Y; Tang J; Zhang Y; Chen J; Zhong Z; He Y; Hu K; Yang J
Int Immunopharmacol; 2024 May; 133():112157. PubMed ID: 38678671
[TBL] [Abstract][Full Text] [Related]
23. A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells.
Kim BH; Yin CH; Guo Q; Bach EA; Lee H; Sandoval C; Jayabose S; Ulaczyk-Lesanko A; Hall DG; Baeg GH
Mol Cancer Ther; 2008 Sep; 7(9):2672-80. PubMed ID: 18790749
[TBL] [Abstract][Full Text] [Related]
24. Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway.
Li JY; Yu J; Du XS; Zhang HM; Wang B; Guo H; Bai J; Wang JH; Liu A; Wang YL
Oncol Rep; 2016 Jul; 36(1):147-54. PubMed ID: 27177149
[TBL] [Abstract][Full Text] [Related]
25. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
26. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
[TBL] [Abstract][Full Text] [Related]
27. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
[TBL] [Abstract][Full Text] [Related]
28. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
Zhang X; Yin P; DI D; Luo G; Zheng L; Wei J; Zhang J; Shi Y; Zhang J; Xu N
Anticancer Res; 2009 Nov; 29(11):4497-501. PubMed ID: 20032397
[TBL] [Abstract][Full Text] [Related]
29. Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity.
Kim JK; Kim JY; Kim HJ; Park KG; Harris RA; Cho WJ; Lee JT; Lee IK
PLoS One; 2013; 8(11):e80391. PubMed ID: 24260381
[TBL] [Abstract][Full Text] [Related]
30. Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer.
Lee JH; Kim C; Baek SH; Ko JH; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
Oncotarget; 2017 Mar; 8(11):17700-17711. PubMed ID: 27458171
[TBL] [Abstract][Full Text] [Related]
31. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
[TBL] [Abstract][Full Text] [Related]
32. Induction of autophagy biomarker BNIP3 requires a JAK2/STAT3 and MT1-MMP signaling interplay in Concanavalin-A-activated U87 glioblastoma cells.
Pratt J; Annabi B
Cell Signal; 2014 May; 26(5):917-24. PubMed ID: 24462646
[TBL] [Abstract][Full Text] [Related]
33. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
[TBL] [Abstract][Full Text] [Related]
34. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
[TBL] [Abstract][Full Text] [Related]
35. Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway.
Xu L; Qiu S; Yang L; Xu H; Liu X; Fan S; Cui R; Fu W; Zhao C; Shen L; Wang L; Huang X
Mol Carcinog; 2019 Aug; 58(8):1512-1525. PubMed ID: 31069881
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B.
Silva IT; Carvalho A; Lang KL; Dudek SE; Masemann D; Durán FJ; Caro MS; Rapp UR; Wixler V; Schenkel EP; Simões CM; Ludwig S
PLoS One; 2015; 10(2):e0117794. PubMed ID: 25674792
[TBL] [Abstract][Full Text] [Related]
37. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
[TBL] [Abstract][Full Text] [Related]
38. 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways.
Kim SM; Kim C; Bae H; Lee JH; Baek SH; Nam D; Chung WS; Shim BS; Lee SG; Kim SH; Sethi G; Ahn KS
Mol Carcinog; 2015 Oct; 54(10):1132-46. PubMed ID: 24962868
[TBL] [Abstract][Full Text] [Related]
39. Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-κB survival pathway in A375-S2 cells.
He H; Zang LH; Feng YS; Chen LX; Kang N; Tashiro S; Onodera S; Qiu F; Ikejima T
J Ethnopharmacol; 2013 Jul; 148(2):544-55. PubMed ID: 23684722
[TBL] [Abstract][Full Text] [Related]
40. A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway.
Zhang Z; Mao H; Du X; Zhu J; Xu Y; Wang S; Xu X; Ji P; Yu Y; Cao B; Han K; Hou T; Xu Z; Kong Y; Jiang G; Tang X; Qiao C; Mao X
Oncotarget; 2016 Feb; 7(8):9296-308. PubMed ID: 26814430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
